Overview

A Trial of EvonailĀ® Solution for Prevention or Treatment of Onycholysis

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This study is a prospective randomized controlled study of EVONAILĀ® solution for prevention or treatment of onycholysis in patients with breast cancer receiving docetaxel chemotherapy.
Phase:
N/A
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Pharmaceutical Solutions